Back to search

Article

The Adenosine A2A Receptor Antagonist KW6002 Mitigates Aldosterone-induced Central Serous Chorioretinopathy in Mice

2026-01-13

Abstract excerpt

<title>Abstract</title> <p> Purpose Central serous chorioretinopathy (CSC), a prevalent disease characterized by choroidal vascular abnormalities, has extremely limited treatment options. This study investigates the effects of the selective adenosine A <sub>2A</sub> receptor (A <sub>2A</sub> R) antagonist KW6002 on choroidal vascular hyperpermeability and the blood-retinal barrier (BRB), and explores its th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
09a9d6da-e63d-5c74-966f-b4c4da9d4afc
DOI
10.21203/rs.3.rs-8526598/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Adenosine A2A Receptor Antagonist KW6002 Mitigates Aldosterone-induced Central Serous Chorioretinopathy in MiceDOI 10.21203/rs.3.rs-8526598/v1
Select a neighboring publication to make it the new centre.